Alzheimer's Disease Research Today is a free monthly online journal that collates and summarizes the latest research about Alzheimer's Disease, including details on diagnosis, memory loss, heredity, treatment, medication.

Volume 3 (2006), Issue 12 (December)

1. New Alzheimer's disease locus on chromosome 8.
   J Med Genet, 43(12): 931-5. [Abstract] [Full-text]
2. Insights into the mechanisms of action of anti-Abeta antibodies in Alzheimer's disease mouse models.
   FASEB J, 20(14): 2576-8. [Abstract] [Full-text]
3. ADAM19 is tightly associated with constitutive Alzheimer's disease APP alpha-secretase in A172 cells.
   Biochem Biophys Res Commun, 352(1): 111-7. [Abstract] [Full-text]
4. The prevalence of Alzheimer neuropathologic lesions is similar in blacks and whites.
   J Neuropathol Exp Neurol, 65(12): 1143-8. [Abstract] [Full-text]
5. Neuronal pentraxin 1 contributes to the neuronal damage evoked by amyloid-beta and is overexpressed in dystrophic neurites in Alzheimer's brain.
   J Neurosci, 26(49): 12735-47. [Abstract] [Full-text]
6. Diabetes is related to cerebral infarction but not to AD pathology in older persons.
   Neurology, 67(11): 1960-5. [Abstract] [Full-text]
7. Body mass index in older persons is associated with Alzheimer disease pathology.
   Neurology, 67(11): 1949-54. [Abstract] [Full-text]
8. Survival and mortality differences between dementia with Lewy bodies vs Alzheimer disease.
   Neurology, 67(11): 1935-41. [Abstract] [Full-text]
9. Berberine chloride can ameliorate the spatial memory impairment and increase the expression of interleukin-1beta and inducible nitric oxide synthase in the rat model of Alzheimer's disease.
   BMC Neurosci, 7: 78. [Abstract] [Full-text]
10. Small-world networks and functional connectivity in Alzheimer's disease.
    Cereb Cortex, 17(1): 92-9. [Abstract] [Full-text]
11. Category-specific visual identification of filtered objects in Alzheimer's disease.
    Arch Gerontol Geriatr, 44(2): 125-39. [Abstract] [Full-text]
12. Linear measures of temporal lobe atrophy on brain magnetic resonance imaging (MRI) but not visual rating of white matter changes can help discrimination of mild cognitive impairment (MCI) and Alzheimer's disease (AD).
    Arch Gerontol Geriatr, 44(2): 141-51. [Abstract] [Full-text]
13. Disease-modifying trials in Alzheimer's disease: a European task force consensus.
    Lancet Neurol, 6(1): 56-62. [Abstract] [Full-text]
14. The relationship between cerebral Alzheimer's disease pathology and odour identification in old age.
    J Neurol Neurosurg Psychiatry, 78(1): 30-5. [Abstract] [Full-text]
15. Antipsychotics and cognitive decline in Alzheimer's disease: the LASER-Alzheimer's disease longitudinal study.
    J Neurol Neurosurg Psychiatry, 78(1): 25-9. [Abstract] [Full-text]
16. Chronic dietary alpha-lipoic acid reduces deficits in hippocampal memory of aged Tg2576 mice.
    Neurobiol Aging, 28(2): 213-25. [Abstract] [Full-text]
17. Brain event-related potentials: diagnosing early-stage Alzheimer's disease.
    Neurobiol Aging, 28(2): 194-201. [Abstract] [Full-text]
18. Vessel ultrastructure in APP23 transgenic mice after passive anti-Abeta immunotherapy and subsequent intracerebral hemorrhage.
    Neurobiol Aging, 28(2): 202-12. [Abstract] [Full-text]
19. Chloroquine-induced endocytic pathway abnormalities: Cellular model of GM1 ganglioside-induced Abeta fibrillogenesis in Alzheimer's disease.
    FEBS Lett, 580(30): 6972-6. [Abstract] [Full-text]
20. PET of brain amyloid and tau in mild cognitive impairment.
    N Engl J Med, 355(25): 2652-63. [Abstract] [Full-text]
21. Androgens regulate the development of neuropathology in a triple transgenic mouse model of Alzheimer's disease.
    J Neurosci, 26(51): 13384-9. [Abstract] [Full-text]
22. Subcutaneous Nogo receptor removes brain amyloid-beta and improves spatial memory in Alzheimer's transgenic mice.
    J Neurosci, 26(51): 13279-86. [Abstract] [Full-text]
23. Extent and distribution of white matter hyperintensities in normal aging, MCI, and AD.
    Neurology, 67(12): 2192-8. [Abstract] [Full-text]
24. Social-economic costs and quality of life of Alzheimer disease in the Canary Islands, Spain.
    Neurology, 67(12): 2186-91. [Abstract] [Full-text]
25. Dissecting the signaling pathway of nicotine-mediated neuroprotection in a mouse Alzheimer disease model.
    FASEB J, 21(1): 61-73. [Abstract] [Full-text]

© 2004-2008 Alzheimer's Disease Research Today. All Rights Reserved.